Statement on the Collection of COVID-19 Data in Cancer Registries

  • 1.  Statement on the Collection of COVID-19 Data in Cancer Registries

    Posted 04-22-2020 19:03

    Dear Colleagues,


    We understand that the COVID-19 pandemic has had and will continue to have far-reaching consequences for cancer patients, both directly, for those infected, and indirectly in the form of treatment and other delays. It is important that we be able to monitor, assess and analyze these impacts and their effect on patient outcomes. Therefore, we are assembling a task force comprised of experts from NCI, CDC, NAACCR, NCRA, CoC and central and hospital registries, to strategize methods and standards for collection of COVID-19 status among cancer patients, as well as the impact of the pandemic on treatment and other clinical decision-making. We will also be assessing the potential impact on registry operations.


    We are sensitive to the fact that many central and hospital cancer registries are operating under a great deal of strain at the present time, with personnel being furloughed or reassigned and the disruption caused by working remotely. We will aim to minimize the additional burden, as much as possible, any COVID-19 data collection places on registries and registrars. 


    Thank you,



    Stephanie M. Hill, MPH, CTR

    Associate Director

    NAACCR small

    2050 West Iles Ave, Suite A, Springfield, IL 62704 |p. 217.698.0800 x117|f. 217.698.0188|